Supporting Statement B

64 - Supporting Statement Part B_clean_5 June 2020.docx

Generic Clearance for Medicaid and CHIP State Plan, Waiver, and Program Submissions (CMS-10398)

Supporting Statement B

OMB: 0938-1148

Document [docx]
Download: docx | pdf

Supporting Statement – Part B


Collections of Information Employing Statistical Methods



1. Describe (including a numerical estimate) the potential respondent universe and any sam­pling or other respondent selection method to be used. Data on the number of entities (e.g., establishments, State and local government units, households, or persons) in the universe covered by the collection and in the corre­sponding sample are to be provided in tabular form for the universe as a whole and for each of the strata in the proposed sample. Indicate expected response rates for the collection as a whole. If the collection had been conducted previously, include the actual response rate achieved during the last collection.


The respondent universe consists of state Medicaid directors (or a designated respondent) and director of the single state agency for substance abuse (or a designated respondent)from each state with a section1115 substance use disorder (SUD) demonstration. The current number of states with a section 1115 SUD demonstration is 27 (including the District of Columbia). We intend to sample the universe of respondents. Because of the small sample size, the requirement for states with a section 1115 demonstration to cooperate with CMS’s federal independent evaluator, and our procedures to minimize response burden, we expect a 100% response rate.


2. Describe the procedures for the collection of information including:


- Statistical methodology for stratification and sample selection,

Our data collection includes all participating states and thus we will not use a sampling strategy.


We will conduct the Demonstration Characteristics Interview with the state Medicaid director or their designated staff and will conduct the Implementation Interview with both the state Medicaid director and the director of the single state agency for substance abuse or their designated staff. A protocol has been created for each set of interviews. The implementation interview will also use a demonstration features grid. We will prepopulate the grid with information abstracted from state demonstration documents. Prior to the implementation interview we will send the prepopulated grid to state Medicaid directors to review and provide clarifications and missing information. During the interview we will use the grid to guide the discussion.


- Estimation procedure,


An estimation procedure is not applicable


- Degree of accuracy needed for the pur­pose described in the justification


This is not applicable because we will not have an estimation procedure and will need 100% accuracy identifying respondents.


- Unusual problems requiring specialized sampling procedures, and


No specialized sampling procedures are necessary.


- Any use of periodic (less frequent than annual) data collection cycles to reduce burden.


This is a one-time data collection. We plan to conduct subsequent interviews annually, but those data collections are not included in this request because their focus will be identified, and protocols will be developed closer to the data collection period.


3. Describe methods to maximize response rates and to deal with issues of non-response. The accuracy and reliability of information collected must be shown to be adequate for intended uses. For collections based on sam­pling, a special justification must be provid­ed for any collection that will not yield 'reliable' data that can be generalized to the uni­verse studied.


Per the interview protocol in the Supporting Statement Part A, we are implementing strategies to reduce burden and increase response. Initial contacts will be made through the CMS project officer that is in regular contact with the state (Attachments 1.a. & 2.a.) RTI will immediately follow-up with states to make direct contact and schedule a call at a time dictated by the respondent (Attachments 1.b. & 2b.). The team will follow-up after a period of non-response and will work the CMS project officer to ensure participation.


4. Describe any tests of procedures or methods to be undertaken. Testing is encouraged as an effective means of refining collections of information to minimize burden and improve utility. Tests must be approved if they call for answers to identical questions from 10 or more respondents. A proposed test or set of tests may be submitted for approval separate­ly or in combination with the main collection of information.


We adapted the program characteristics grid (Attachment 1.b.) from a template used for abstracting data on awardee features for another CMS meta-evaluation. The approaches to conducting qualitative data collection outlined in Supporting Statement Part A, including the interview protocols, are based on similar evaluations RTI has conducted for federal agencies.


5. Provide the name and telephone number of individuals consulted on statistical aspects of the design and the name of the agency unit, contractor(s), grantee(s), or other person(s) who will actually collect and/or analyze the information for the agency.



Name

Telephone number

Agency unit, contractor, grantee, or other persons

Jesse Hinde

919-541-1209

RTI International

Tami Mark

301-816-4612

RTI International

Anna Sommers

202-974-7884

RTI International

Holly Stockdale

781-370-4027

RTI International

Brian Bruen

919-541-6625

RTI International

Katie Quinn

919-541-7008

RTI International

Joshua Clemson

919-541-4057

RTI International

Alex Besser

919-541-8739

RTI International

Kenneth Fassel

202-728-2476

RTI International

Kyle Emery

919-541-6453

RTI International

Anupa Bir

781-434-1708

RTI International

Susan Haber

781-434-1721

RTI International

Michael Trieger

410-786-0745

Centers for Medicare & Medicaid Services (CMS)

Danielle Daly

443-379-3289

Centers for Medicare & Medicaid Services (CMS)



3



File Typeapplication/vnd.openxmlformats-officedocument.wordprocessingml.document
File TitleSupporting Statement – Part B
AuthorCMS
File Modified0000-00-00
File Created2021-01-14

© 2024 OMB.report | Privacy Policy